Form 4: Ginkgo Bioworks CFO Converts Class B Common Stock to Class A
SEC Filing
Mark E. Dmytruk, CFO of Ginkgo Bioworks Holdings, Inc., converted 9,497 shares of Class B Common Stock to Class A Common Stock on March 13, 2025.
Summary
- Mark E. Dmytruk, the Chief Financial Officer of Ginkgo Bioworks Holdings, Inc., filed a Form 4 on March 17, 2025, reporting a transaction that occurred on March 13, 2025.
- The transaction involved the conversion of 9,497 shares of Class B Common Stock into 9,497 shares of Class A Common Stock.
- Following the transaction, Dmytruk directly owns 44,149 shares of Class A Common Stock and 5,914 derivative securities related to Class A Common Stock.
Sentiment
Score: 5
Explanation: This is a routine filing related to stock conversion, and does not indicate positive or negative sentiment.
Industry Context
Form 4 filings are standard practice for company insiders and officers to report changes in their beneficial ownership of company stock, ensuring transparency and compliance with SEC regulations.
Stakeholder Impact
- The conversion of stock has a neutral impact on stakeholders as it is a standard transaction.
Key Dates
| Date | Description |
|---|---|
| 03/13/2025 | Date of transaction: Conversion of Class B Common Stock to Class A Common Stock. |
| 03/17/2025 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.